These compounds may interact with:
Angiopoietin-1 receptor
Potentially involved in: multiple cutaneous and mucosal venous malformations; glaucoma; breast cancer; melanoma; kidney cancer; carcinoma; skin cancer; vascular disease; cancer; diabetic retinopathy; diabetes mellitus; retinopathy of prematurity; glomangioma; congenital arteriovenous malformation; blood coagulation disorders; epilepsy, temporal lobe; exanthema; hemangioma, cavernous; hemangiosarcoma; hemorrhagic disorders
Disease data sourced from Pharos.